Tag: cash

ROK Financial reports rising interest in flexible business lines of credit as small and mid-sized companies seek faster, more adaptable funding options in 2025.

Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and six months ended June 30, 2025. All dollar amounts set out herein are in thousands of Canadian dollars, unless otherwise stated.

EVANSVILLE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Old National Bancorp (the “Company” or “Old National”) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This quarterly cash dividend will be payable on September 15, 2025, to shareholders of record as of the close of business on September 5, 2025.

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2025 (the “Financial Statements”), together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.ca and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated.

All amounts are stated in United States dollars unless otherwise indicated

- Grew Total Revenue 2% Year-over-Year to $42 Million -

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.